Principal Securities, Inc. Veracyte, Inc. Transaction History
Principal Securities, Inc.
- $4.47 Trillion
- Q1 2025
A detailed history of Principal Securities, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 1,909 shares of VCYT stock, worth $48,202. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,909
Previous 1,909
-0.0%
Holding current value
$48,202
Previous $75.6 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding VCYT
# of Institutions
303Shares Held
79.6MCall Options Held
15.5KPut Options Held
16.7K-
Vanguard Group Inc Valley Forge, PA8.26MShares$209 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$197 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.24MShares$132 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.94MShares$99.5 Million1.26% of portfolio
-
Wellington Management Group LLP Boston, MA3.85MShares$97.3 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $1.81B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...